Chemoinformaics analysis of diMethyl Ester (CAS) Methyl phthalate
| Molecular Weight | 194.186 | nRot | 2 |
| Heavy Atom Molecular Weight | 184.106 | nRig | 8 |
| Exact Molecular Weight | 194.058 | nRing | 1 |
| Solubility: LogS | -1.975 | nHRing | 0 |
| Solubility: LogP | 1.671 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 26.5759 |
| nHD | 0 | BPOL | 15.2401 |
| QED | 0.665 |
| Synth | 1.487 |
| Natural Product Likeliness | -0.236 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.454 |
| MDCK | 0.0000395 |
| BBB | 0.848 |
| PPB | 0.380893 |
| VDSS | 0.949 |
| FU | 0.301149 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.903 |
| CYP2c19-inh | 0.928 |
| CYP2c19-sub | 0.261 |
| CYP2c9-inh | 0.488 |
| CYP2c9-sub | 0.819 |
| CYP2d6-inh | 0.034 |
| CYP2d6-sub | 0.396 |
| CYP3a4-inh | 0.078 |
| CYP3a4-sub | 0.204 |
| CL | 11.138 |
| T12 | 0.775 |
| hERG | 0.058 |
| Ames | 0.013 |
| ROA | 0.005 |
| SkinSen | 0.278 |
| Carcinogencity | 0.023 |
| EI | 0.99 |
| Respiratory | 0.048 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.871707 |